Numerion Labs Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$19.8M
- Investors
-
33
Numerion Labs General Information
Description
Operator of an artificial intelligence-based biotechnology company intended to help invent new potential medicines for disease targets. The company's technology helps in drug hit discovery, binding affinity prediction, and toxicity detection, enabling scientists to discover small molecules for the treatment and investigation of human diseases.
Contact Information
Website
www.numerionlabs.aiCorporate Office
- 250 Sutter Street
- Suite 650
- San Francisco, CA 94108
- United States
Corporate Office
- 250 Sutter Street
- Suite 650
- San Francisco, CA 94108
- United States
Numerion Labs Timeline
Numerion Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC (Series D) | 19-Mar-2026 | $19.8M | Completed | Clinical Trials - Phase 1 | ||
| 14. Later Stage VC (Series C) | 18-Feb-2025 | Completed | Pre-Clinical Trials | |||
| 13. Later Stage VC (Series B) | 06-Dec-2020 | Completed | Pre-Clinical Trials | |||
| 12. Grant | 06-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 11. Later Stage VC (Series A) | 02-Jul-2018 | Completed | Pre-Clinical Trials | |||
| 10. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 9. Accelerator/Incubator | 01-Jan-2016 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 05-May-2015 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 24-Mar-2015 | $120K | $220K | Completed | Pre-Clinical Trials | |
| 6. Angel (individual) | $100K | Completed | Startup |
Numerion Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series CC | ||||||||
| Series BB | ||||||||
| Series AA-8 | ||||||||
| Series AA-7 | ||||||||
| Series AA-6 | ||||||||
| Series AA-5 | ||||||||
| Series AA-4 | ||||||||
| Series AA-3 | 1,107,751 | $0.000010 | 8% | $0.22 | $0.22 | 1x | $0.22 | 0.04% |
| Series AA-2 | 159,056 | $0.000010 | 8% | $0.27 | $0.27 | 1x | $0.27 | 0.01% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Numerion Labs Comparisons
Industry
Financing
Details
Numerion Labs Competitors (23)
One of Numerion Labs’s 23 competitors is X-37, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| X-37 | Venture Capital-Backed | South San Francisco, CA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom |
Numerion Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Numerion Labs Patents
Numerion Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260102379-A1 | Inhibitor of pfkfb2 kinase activity and cellular glycolysis | Pending | 14-Oct-2024 | ||
| US-20260048051-A1 | Treatment of inflammatory bowel disease | Pending | 03-Jun-2024 | ||
| WO-2025255156-A1 | Treatment of inflammatory bowel disease | Pending | 03-Jun-2024 | ||
| AU-2024351801-A1 | Systems and methods for identifying compounds in combinatorial libraries having specific molecular properties | Pending | 29-Sep-2023 | ||
| EP-4785334-A1 | Systems and methods for identifying compounds in combinatorial libraries having specific molecular properties | Pending | 29-Sep-2023 | G16C20/64 |
Numerion Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Numerion Labs Investors (33)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cerity Partners Ventures | Corporate Venture Capital | Minority | ||
| Draper Dragon | Venture Capital | Minority | ||
| Sanabil Investments | Growth/Expansion | Minority | ||
| Gates Foundation | Not-For-Profit Venture Capital | |||
| AimTop Ventures | Venture Capital | Minority |
Numerion Labs Investments (7)
Numerion Labs’s most recent deal was a Joint Venture with A2i Therapeutics. The deal was made on 01-Nov-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| A2i Therapeutics | 01-Nov-2020 | Joint Venture | Drug Discovery | ||
| Theia Biosciences | 13-Mar-2020 | Joint Venture | Drug Discovery | ||
| Joint Venture (StemoniX and Atomwise) | 03-Dec-2019 | Joint Venture | Drug Discovery | ||
| Atomwise & Atropos (Joint Venture) | 11-Sep-2019 | Joint Venture | Drug Discovery | ||
| Atomwise & OncoStatyx (Joint Venture) | 10-Sep-2019 | Joint Venture | Drug Discovery |
Numerion Labs FAQs
-
When was Numerion Labs founded?
Numerion Labs was founded in 2012.
-
Where is Numerion Labs headquartered?
Numerion Labs is headquartered in San Francisco, CA.
-
What is the size of Numerion Labs?
Numerion Labs has 18 total employees.
-
What industry is Numerion Labs in?
Numerion Labs’s primary industry is Drug Discovery.
-
Is Numerion Labs a private or public company?
Numerion Labs is a Private company.
-
What is the current valuation of Numerion Labs?
The current valuation of Numerion Labs is .
-
What is Numerion Labs’s current revenue?
The current revenue for Numerion Labs is .
-
How much funding has Numerion Labs raised over time?
Numerion Labs has raised $246M.
-
Who are Numerion Labs’s investors?
Cerity Partners Ventures, Draper Dragon, Sanabil Investments, Gates Foundation, and AimTop Ventures are 5 of 33 investors who have invested in Numerion Labs.
-
Who are Numerion Labs’s competitors?
X-37, Exscientia, Verge Labs, Inovio Pharmaceuticals, and Enterprise Therapeutics are some of the 23 competitors of Numerion Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
